MX9303600A - Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen. - Google Patents

Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.

Info

Publication number
MX9303600A
MX9303600A MX9303600A MX9303600A MX9303600A MX 9303600 A MX9303600 A MX 9303600A MX 9303600 A MX9303600 A MX 9303600A MX 9303600 A MX9303600 A MX 9303600A MX 9303600 A MX9303600 A MX 9303600A
Authority
MX
Mexico
Prior art keywords
imidazolyl
derivatives
phenylpropionic
cynamic
procedure
Prior art date
Application number
MX9303600A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich E Muller
Jurgen Dressel
Peter Fey
Rudolf H Hanko
Walter Hubsch
Thomas Kramer Stanislav Kazda
Matthias Muller-Gliemann
Martin Beuck Johannes P Stasch
Andreas Knorr Stefan Wohlfeil
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX9303600A publication Critical patent/MX9303600A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9303600A 1992-06-26 1993-06-16 Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen. MX9303600A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4220983A DE4220983A1 (de) 1992-06-26 1992-06-26 Imidazolyl-substituierte Phenylpropion- und -zimtsäurederivate

Publications (1)

Publication Number Publication Date
MX9303600A true MX9303600A (es) 1993-12-01

Family

ID=6461888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303600A MX9303600A (es) 1992-06-26 1993-06-16 Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.

Country Status (17)

Country Link
US (1) US5414008A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0578002A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0665209A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR940000434A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1082041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU4006393A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2099068A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ117493A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4220983A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI932953A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT65190A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106108A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9303600A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO932132L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK66793A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW239132B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA934584B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739181D1 (de) 1996-08-12 2009-02-05 Celgene Corp Neue immunotherapeutische Mittel und deren Verwendung in der Reduzierung von Cytokinenspiegel
US7165676B2 (en) * 2002-04-19 2007-01-23 Smurfit-Stone Container Enterprises, Inc. Heat seal blister package having improved moisture vapor transmission barrier and method for forming same
US7470723B2 (en) * 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
KR20050117533A (ko) * 2003-03-05 2005-12-14 셀진 코포레이션 디페닐에틸렌 화합물 및 그의 용도
BRPI0514857A (pt) * 2004-09-03 2008-05-06 Celgene Corp composto ou um sal, solvato ou hidrato farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos para inibir a angiogênese, para inibir ou reduzir a polimerização da tubulina ou a estabilidade da tubulina em uma célula, para inibir a atividade de pde4 em uma célula, para inibir atividade do fator-alfa de necrose de tumor (tnf-alfa) em uma célula, para tratar ou melhorar um distúrbio inflamatório, para tratar ou melhorar cáncer, para inibir a proliferação de célula cancerosa, para marcar, bloquear ou destruir a função de vasculatura tumoral, para marcar, bloquear ou destruir o endotélio de vasos tumor, para marcar, bloquear ou destruir a função de vasculatura tumoral e inibir a angiogênese em um tumor e para tratar ou melhorar um distúrbio do sistema nervoso central
WO2008030448A1 (en) * 2006-09-07 2008-03-13 Millennium Pharmaceuticals, Inc. Phenethylamide derivatives with kinase inhibitory activity
SI3307739T1 (sl) * 2015-06-15 2021-03-31 Glaxosmithkline Intellectual Property Development Limited NRF2 regulatorji
CN115557898B (zh) * 2021-07-01 2024-08-20 诸葛国琴 一种咪唑类化合物、其中间体及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3130254A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(4-((omega)'-(1-imidazolyl)-alkyl)-phenyl)-(omega)-oxo-alkancarbonsaeuren und deren derivae, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3424944A1 (de) * 1984-07-06 1986-02-06 Hoechst Ag, 6230 Frankfurt Neue imidazolyverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
US5183810A (en) * 1990-02-13 1993-02-02 Merck & Co., Inc. Imidazole angiotensin II antagonists incorporating a substituted benzyl element
JP2626167B2 (ja) * 1990-05-18 1997-07-02 日産自動車株式会社 四輪駆動車のトランスファー装置

Also Published As

Publication number Publication date
HU9301871D0 (en) 1993-09-28
SK66793A3 (en) 1994-02-02
CZ117493A3 (en) 1994-01-19
IL106108A0 (en) 1993-10-20
KR940000434A (ko) 1994-01-03
CA2099068A1 (en) 1993-12-27
FI932953A0 (fi) 1993-06-24
HUT65190A (en) 1994-05-02
JPH0665209A (ja) 1994-03-08
ZA934584B (en) 1994-02-01
TW239132B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-01-21
US5414008A (en) 1995-05-09
DE4220983A1 (de) 1994-01-05
AU4006393A (en) 1994-01-06
CN1082041A (zh) 1994-02-16
EP0578002A1 (de) 1994-01-12
FI932953A7 (fi) 1993-12-27
NO932132L (no) 1993-12-27
NO932132D0 (no) 1993-06-10

Similar Documents

Publication Publication Date Title
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
SV1995000062A (es) DERIVADOS DE CICLOALCANO-INDOL Y - AZAINDOL REF. Le A 30 699
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
ES2122076T3 (es) Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
MX9300630A (es) Derivados de amidina, procedimiento para su preparacion y medicamentos que los contienen.
ES2059729T3 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
HUT62575A (en) Process for producing substituted imidazole derivatives and pharmaceutical compositions comprising same
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
AU5112479A (en) Medicated animal feed based on liver meal
MX9301125A (es) Derivados del acido fenilacetico sustituido, procedimiento para la obtencion de los mismos, medicamentos que los contienen y procedimiento para la obtencion de tales medicamentos.
MX9303600A (es) Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.
MX9302461A (es) Benzo-y piridopiridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
MX9207557A (es) Derivados de acidos benzofuranil- y tiofenilmetiltio-alcanocarboxilicos, procedimiento para su preparacion y medicamentos que los contienen.
MX9301126A (es) Fenilacetamidas sustituidas por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.
MX9306419A (es) Bifenilos trisustituidos, procedimiento para su obtencion y medicamentos que los contienen.
ES2054177T3 (es) Derivados disubstituidos del acido (quinolin-2-il-metoxi)fenilacetico.
NO890046L (no) Disubstituerte pyridiner.
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
ES2077354T3 (es) Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.